Breadcrumb
- Home
- Market & Technical Intelligence
- Life Sciences
- Diagnostics
- Report Information
Global Medical Aesthetics Market Research Report—Forecast till 2025
Publisher: Market Research Future
Published: 2019/12/01
Page: 152
Format: PDF
Price:
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Global Medical Aesthetics Market: Information by Product ( Facial Aesthetic, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Tattoo Removal Devices and others), by End User (Hospitals & Clinics, Dermatology & Cosmetic Centers and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025
Market analysis
The Global Medical Aesthetics Market is expected to exhibit lucrative growth during the forecast period. Medical Aesthetics Market is expected to register a CAGR of 12.97% to reach USD 23,544.18 Million by 2025. The rising incidences of skin diseases, swelling expenditure on cosmetic and aesthetic procedures, growing acceptance of facial aesthetics, technological advancements in the aesthetics industry, snowballing demand for aesthetic procedures such as liposuction, hair transplantation, and others are likely to drive the growth of the global medical aesthetics market during the forecast period. For instance, in 2016, according to the International Society of Aesthetic Plastic Surgery, an estimated 18,447 liposuction procedures were performed in Taipei, accounting for 1.3% of the total surgical liposuction systems across the globe. Moreover, it was determined that India stood third in liposuction procedures, representing 5.0% of the total liposuction procedures performed in the world. One of the significant factors characterizing the market growth is the increasing demand for aesthetic procedures such as liposuction and hair replacement. However, the side-effects coupled with aesthetics procedures are anticipated to limit market growth over the forecast period. Generally, as calculated in the year 2018, the market was guided by Asia-Pacific supported by Americas and
Market segmentation
The global medical aesthetics market is segmented based on product, end user and region respectively. By end-user, the market has been classified as hospitals & clinics, dermatology & cosmetic centers, and others. In August 2016, Merz Pharma GmbH & Co. KGaA acquired an aesthetic medical device company, ON Light Sciences. By this achievement, the company announced the field of light science innovation technology and aimed to meet the needs of aesthetic practices that focus on energy-based devices. On the basis of product, the global medical aesthetics market has been classified into facial aesthetics, body contouring devices, cosmetic implants, hair removal devices, aesthetic skin devices, tattoo removal devices, others. In August 2018, Hologic Inc.’s Cynosure division signed a contract with Porter Instrument. With this contract, the company was able to disseminate its products in the US and Canada. Facial aesthetic products are likely to hold a limit market share of 30.3% during the forecast period.
Regional analysis
Geographically the global medical aesthetics market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The European medical aesthetics market comprises Eastern Europe and Western Europe. Western Europe comprises countries such as Germany, the UK, France, Italy, and Spain. Europe accounts for the second-largest market for global aesthetics owing to the increasing support from the government, the presence of a huge geriatric population, and high healthcare spending. The Global Medical Aesthetics Market in the Americas is segmented into North America and Latin America. In this region, North America is expected to overshadow the market. The Americas is expected to command the largest market share due to a well-developed healthcare sector, growing demand for beauty treatments and other anti-aging related cosmetic procedures, and the presence of leading players. Additionally, an increasing number of aesthetic surgeries are likely to drive the growth of the medical aesthetics market in these countries. According to the American Society of Plastic Surgeons, in 2016, nearly 17.5 million cosmetic procedures and 5.8 million reconstructive procedures were registered. The Middle East & Africa is anticipated to hold the lowest market share in the Global Medical Aesthetics Market. In this region, the Middle East is expected to dominate the market owing to the presence of a well-developed healthcare sector. The growth of the market is majorly attributed to the developing healthcare infrastructure, the undeveloped market in this region, and continuously increasing demand for products. The Asia-Pacific region is the fastest-growing market for the global medical aesthetics market. The presence of a vast patient population, rapid development in technology, and the presence of enormous opportunities for the development of the market drive the growth of the medical aesthetics market in Asia-Pacific. The government of this region is also looking forward to availing better treatment options from developed nations to improve the quality of life of their citizens. This region is expected to grow at a CAGR of 13.31% during the forecast period of 2019 to 2025.
Major players
The proposed spectators in the global medical aesthetics market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the global medical aesthetics market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the global medical aesthetics market are companies like Allergan, Merz Pharma GmbH & Co. KGaA, Syneron Medical Ltd, Hologic Inc., Cutera, Lumenis, Galderma SA, Bausch Health/ Valeant Pharmaceuticals, Anika Therapeutics Inc., and Alma Lasers.
Market analysis
The Global Medical Aesthetics Market is expected to exhibit lucrative growth during the forecast period. Medical Aesthetics Market is expected to register a CAGR of 12.97% to reach USD 23,544.18 Million by 2025. The rising incidences of skin diseases, swelling expenditure on cosmetic and aesthetic procedures, growing acceptance of facial aesthetics, technological advancements in the aesthetics industry, snowballing demand for aesthetic procedures such as liposuction, hair transplantation, and others are likely to drive the growth of the global medical aesthetics market during the forecast period. For instance, in 2016, according to the International Society of Aesthetic Plastic Surgery, an estimated 18,447 liposuction procedures were performed in Taipei, accounting for 1.3% of the total surgical liposuction systems across the globe. Moreover, it was determined that India stood third in liposuction procedures, representing 5.0% of the total liposuction procedures performed in the world. One of the significant factors characterizing the market growth is the increasing demand for aesthetic procedures such as liposuction and hair replacement. However, the side-effects coupled with aesthetics procedures are anticipated to limit market growth over the forecast period. Generally, as calculated in the year 2018, the market was guided by Asia-Pacific supported by Americas and
Market segmentation
The global medical aesthetics market is segmented based on product, end user and region respectively. By end-user, the market has been classified as hospitals & clinics, dermatology & cosmetic centers, and others. In August 2016, Merz Pharma GmbH & Co. KGaA acquired an aesthetic medical device company, ON Light Sciences. By this achievement, the company announced the field of light science innovation technology and aimed to meet the needs of aesthetic practices that focus on energy-based devices. On the basis of product, the global medical aesthetics market has been classified into facial aesthetics, body contouring devices, cosmetic implants, hair removal devices, aesthetic skin devices, tattoo removal devices, others. In August 2018, Hologic Inc.’s Cynosure division signed a contract with Porter Instrument. With this contract, the company was able to disseminate its products in the US and Canada. Facial aesthetic products are likely to hold a limit market share of 30.3% during the forecast period.
Regional analysis
Geographically the global medical aesthetics market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The European medical aesthetics market comprises Eastern Europe and Western Europe. Western Europe comprises countries such as Germany, the UK, France, Italy, and Spain. Europe accounts for the second-largest market for global aesthetics owing to the increasing support from the government, the presence of a huge geriatric population, and high healthcare spending. The Global Medical Aesthetics Market in the Americas is segmented into North America and Latin America. In this region, North America is expected to overshadow the market. The Americas is expected to command the largest market share due to a well-developed healthcare sector, growing demand for beauty treatments and other anti-aging related cosmetic procedures, and the presence of leading players. Additionally, an increasing number of aesthetic surgeries are likely to drive the growth of the medical aesthetics market in these countries. According to the American Society of Plastic Surgeons, in 2016, nearly 17.5 million cosmetic procedures and 5.8 million reconstructive procedures were registered. The Middle East & Africa is anticipated to hold the lowest market share in the Global Medical Aesthetics Market. In this region, the Middle East is expected to dominate the market owing to the presence of a well-developed healthcare sector. The growth of the market is majorly attributed to the developing healthcare infrastructure, the undeveloped market in this region, and continuously increasing demand for products. The Asia-Pacific region is the fastest-growing market for the global medical aesthetics market. The presence of a vast patient population, rapid development in technology, and the presence of enormous opportunities for the development of the market drive the growth of the medical aesthetics market in Asia-Pacific. The government of this region is also looking forward to availing better treatment options from developed nations to improve the quality of life of their citizens. This region is expected to grow at a CAGR of 13.31% during the forecast period of 2019 to 2025.
Major players
The proposed spectators in the global medical aesthetics market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the global medical aesthetics market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the global medical aesthetics market are companies like Allergan, Merz Pharma GmbH & Co. KGaA, Syneron Medical Ltd, Hologic Inc., Cutera, Lumenis, Galderma SA, Bausch Health/ Valeant Pharmaceuticals, Anika Therapeutics Inc., and Alma Lasers.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 15
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 RESEARCH OBJECTIVE 17
2.4 MARKET STRUCTURE 18
2.5 ASSUMPTIONS & LIMITATIONS 18
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 OVERVIEW 28
4.2 DRIVERS 29
4.2.1 HIGH DEMAND FOR LIPOSUCTION, HAIR TRANSPLANTATION, AND THE RISING OBESE AND GERIATRIC POPULATION 29
4.2.2 GROWING EXPENDITURE ON COSMETIC SURGERIES 29
4.2.3 PREVALENCE OF SKIN DISEASES 30
4.2.4 TECHNOLOGICAL ADVANCEMENTS IN THE AESTHETIC INDUSTRY 30
4.2.5 INCREASING ACCEPTANCE OF FACIAL AESTHETICS 30
4.3 RESTRAINTS 31
4.3.1 HIGH PROCEDURAL COSTS 31
4.3.2 LACK OF TRAINING FOR AESTHETIC PROCEDURES 31
4.3.3 SIDE-EFFECTS ASSOCIATED WITH AESTHETICS PROCEDURES 32
4.4 OPPORTUNITIES 33
4.4.1 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 35
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 RESEARCH & DEVELOPMENT 37
5.2.2 MANUFACTURING 37
5.2.3 DISTRIBUTION 37
5.2.4 MARKETING & SALES 37
5.2.5 POST-SALES MONITORING 37
5.3 INVESTMENT OPPORTUNITIES 38
5.4 PRICE ANALYSIS 38
6 GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT
6.1 OVERVIEW 39
6.2 FACIAL AESTHETIC 41
6.2.1 BOTULINUM TOXIN 41
6.2.2 DERMAL FILLERS 42
6.2.3 MICRODERMABRASION DEVICES 42
6.2.4 OTHERS 43
6.3 BODY CONTOURING DEVICES 43
6.3.1 NONSURGICAL FAT REDUCTION DEVICES 44
6.3.2 CELLULITE REDUCTION DEVICES 45
6.3.3 LIPOSUCTION DEVICES 45
6.4 COSMETIC IMPLANTS 46
6.4.1 BREAST IMPLANTS 47
6.4.2 FACIAL IMPLANTS 47
6.4.3 OTHERS 47
6.5 HAIR REMOVAL DEVICES 48
6.6 SKIN AESTHETIC DEVICES 48
6.6.1 LASER SKIN RESURFACING DEVICES 49
6.6.2 NONSURGICAL SKIN TIGHTENING DEVICES 50
6.6.3 MICRO-NEEDLING PRODUCTS 50
6.6.4 LIGHT THERAPY DEVICE 51
6.7 TATTOO REMOVAL DEVICES 51
6.8 OTHERS 52
7 GLOBAL MEDICAL AESTHETICS MARKET, BY END USER
7.1 OVERVIEW 53
7.2 HOSPITALS & CLINICS 54
7.3 DERMATOLOGY & COSMETIC CENTERS 54
7.4 OTHERS 55
8 GLOBAL MEDICAL AESTHETICS MARKET, BY REGION
8.1 OVERVIEW 56
8.2 AMERICAS 58
8.2.1 NORTH AMERICA 60
8.2.2 LATIN AMERICA 68
8.3 EUROPE 71
8.3.1 GERMANY 74
8.3.2 FRANCE 77
8.3.3 UK 79
8.3.4 ITALY 82
8.3.5 SPAIN 84
8.3.6 IRELAND 87
8.3.7 REST OF EUROPE 89
8.4 ASIA-PACIFIC 92
8.4.1 CHINA 95
8.4.2 JAPAN 98
8.4.3 SOUTH KOREA 100
8.4.4 INDIA 103
8.4.5 AUSTRALIA 105
8.4.6 REST OF ASIA-PACIFIC 108
8.5 MIDDLE EAST & AFRICA 111
8.5.1 MIDDLE EAST 114
8.5.2 AFRICA 116
10 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION 119
9.2 COMPETITIVE BENCHMARKING 120
9.3 KEY DEVELOPMENTS 121
11 COMPANY PROFILES
10.1 ALLERGAN 123
10.1.1 COMPANY OVERVIEW 123
10.1.2 FINANCIAL OVERVIEW 123
10.1.3 PRODUCTS/SERVICES OFFERED 124
10.1.4 ALLERGAN: KEY DEVELOPMENTS 124
10.1.5 SWOT ANALYSIS 125
10.1.6 KEY STRATEGIES 125
10.2 MERZ PHARMA GMBH & CO. KGAA 126
10.2.1 COMPANY OVERVIEW 126
10.2.2 FINANCIAL OVERVIEW 126
10.2.3 PRODUCTS/SERVICES OFFERED 127
10.2.4 KEY DEVELOPMENTS 127
10.2.5 SWOT ANALYSIS 128
10.2.6 KEY STRATEGIES 128
10.3 LUMENIS 129
10.3.1 COMPANY OVERVIEW 129
10.3.2 FINANCIAL OVERVIEW 129
10.3.3 PRODUCTS/SERVICES OFFERED 129
10.3.4 KEY DEVELOPMENTS 130
10.3.5 SWOT ANALYSIS 130
10.3.6 KEY STRATEGIES 130
10.4 HOLOGIC INC. 131
10.4.1 COMPANY OVERVIEW 131
10.4.2 FINANCIAL OVERVIEW 131
10.4.3 PRODUCTS/SERVICES OFFERED 132
10.4.4 KEY DEVELOPMENTS 132
10.4.5 SWOT ANALYSIS 133
10.4.6 KEY STRATEGIES 133
10.5 GALDERMA SA 134
10.5.1 COMPANY OVERVIEW 134
10.5.2 FINANCIAL OVERVIEW 134
10.5.3 PRODUCTS/SERVICES OFFERED 135
10.5.4 KEY DEVELOPMENTS 135
10.5.5 SWOT ANALYSIS 135
10.5.6 KEY STRATEGIES 136
10.6 BAUSCH HEALTH (VALEANT PHARMACEUTICALS) 137
10.6.1 COMPANY OVERVIEW 137
10.6.2 FINANCIAL OVERVIEW 137
10.6.3 PRODUCTS/SERVICES OFFERED 138
10.6.4 KEY DEVELOPMENTS 138
10.6.5 SWOT ANALYSIS 138
10.6.6 KEY STRATEGIES 139
10.7 ANIKA THERAPEUTICS INC. 140
10.7.1 COMPANY OVERVIEW 140
10.7.2 FINANCIAL OVERVIEW 140
10.7.3 PRODUCTS/SERVICES OFFERED 141
10.7.4 KEY DEVELOPMENTS 141
10.7.5 SWOT ANALYSIS 141
10.7.6 KEY STRATEGIES 141
10.8 CUTERA 142
10.8.1 COMPANY OVERVIEW 142
10.8.2 FINANCIAL OVERVIEW 142
10.8.3 PRODUCTS/SERVICES OFFERED 143
10.8.4 KEY DEVELOPMENTS 143
10.8.5 SWOT ANALYSIS 144
10.8.6 KEY STRATEGIES 144
10.9 ALMA LASERS 145
10.9.1 COMPANY OVERVIEW 145
10.9.2 FINANCIAL OVERVIEW 145
10.9.3 PRODUCTS/SERVICES OFFERED 146
10.9.4 KEY DEVELOPMENTS 146
10.9.5 SWOT ANALYSIS 147
10.9.6 KEY STRATEGIES 147
10.10 SYNERON MEDICAL LTD 148
10.10.1 COMPANY OVERVIEW 148
10.10.2 FINANCIAL OVERVIEW 148
10.10.3 PRODUCTS/SERVICES OFFERED 148
10.10.4 KEY DEVELOPMENTS 148
10.10.5 SWOT ANALYSIS 149
10.10.6 KEY STRATEGIES 149
12 APPENDIX
11.1 REFERENCES 150
11.2 RELATED REPORTS 151
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 15
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 RESEARCH OBJECTIVE 17
2.4 MARKET STRUCTURE 18
2.5 ASSUMPTIONS & LIMITATIONS 18
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 OVERVIEW 28
4.2 DRIVERS 29
4.2.1 HIGH DEMAND FOR LIPOSUCTION, HAIR TRANSPLANTATION, AND THE RISING OBESE AND GERIATRIC POPULATION 29
4.2.2 GROWING EXPENDITURE ON COSMETIC SURGERIES 29
4.2.3 PREVALENCE OF SKIN DISEASES 30
4.2.4 TECHNOLOGICAL ADVANCEMENTS IN THE AESTHETIC INDUSTRY 30
4.2.5 INCREASING ACCEPTANCE OF FACIAL AESTHETICS 30
4.3 RESTRAINTS 31
4.3.1 HIGH PROCEDURAL COSTS 31
4.3.2 LACK OF TRAINING FOR AESTHETIC PROCEDURES 31
4.3.3 SIDE-EFFECTS ASSOCIATED WITH AESTHETICS PROCEDURES 32
4.4 OPPORTUNITIES 33
4.4.1 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 35
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 RESEARCH & DEVELOPMENT 37
5.2.2 MANUFACTURING 37
5.2.3 DISTRIBUTION 37
5.2.4 MARKETING & SALES 37
5.2.5 POST-SALES MONITORING 37
5.3 INVESTMENT OPPORTUNITIES 38
5.4 PRICE ANALYSIS 38
6 GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT
6.1 OVERVIEW 39
6.2 FACIAL AESTHETIC 41
6.2.1 BOTULINUM TOXIN 41
6.2.2 DERMAL FILLERS 42
6.2.3 MICRODERMABRASION DEVICES 42
6.2.4 OTHERS 43
6.3 BODY CONTOURING DEVICES 43
6.3.1 NONSURGICAL FAT REDUCTION DEVICES 44
6.3.2 CELLULITE REDUCTION DEVICES 45
6.3.3 LIPOSUCTION DEVICES 45
6.4 COSMETIC IMPLANTS 46
6.4.1 BREAST IMPLANTS 47
6.4.2 FACIAL IMPLANTS 47
6.4.3 OTHERS 47
6.5 HAIR REMOVAL DEVICES 48
6.6 SKIN AESTHETIC DEVICES 48
6.6.1 LASER SKIN RESURFACING DEVICES 49
6.6.2 NONSURGICAL SKIN TIGHTENING DEVICES 50
6.6.3 MICRO-NEEDLING PRODUCTS 50
6.6.4 LIGHT THERAPY DEVICE 51
6.7 TATTOO REMOVAL DEVICES 51
6.8 OTHERS 52
7 GLOBAL MEDICAL AESTHETICS MARKET, BY END USER
7.1 OVERVIEW 53
7.2 HOSPITALS & CLINICS 54
7.3 DERMATOLOGY & COSMETIC CENTERS 54
7.4 OTHERS 55
8 GLOBAL MEDICAL AESTHETICS MARKET, BY REGION
8.1 OVERVIEW 56
8.2 AMERICAS 58
8.2.1 NORTH AMERICA 60
8.2.2 LATIN AMERICA 68
8.3 EUROPE 71
8.3.1 GERMANY 74
8.3.2 FRANCE 77
8.3.3 UK 79
8.3.4 ITALY 82
8.3.5 SPAIN 84
8.3.6 IRELAND 87
8.3.7 REST OF EUROPE 89
8.4 ASIA-PACIFIC 92
8.4.1 CHINA 95
8.4.2 JAPAN 98
8.4.3 SOUTH KOREA 100
8.4.4 INDIA 103
8.4.5 AUSTRALIA 105
8.4.6 REST OF ASIA-PACIFIC 108
8.5 MIDDLE EAST & AFRICA 111
8.5.1 MIDDLE EAST 114
8.5.2 AFRICA 116
10 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION 119
9.2 COMPETITIVE BENCHMARKING 120
9.3 KEY DEVELOPMENTS 121
11 COMPANY PROFILES
10.1 ALLERGAN 123
10.1.1 COMPANY OVERVIEW 123
10.1.2 FINANCIAL OVERVIEW 123
10.1.3 PRODUCTS/SERVICES OFFERED 124
10.1.4 ALLERGAN: KEY DEVELOPMENTS 124
10.1.5 SWOT ANALYSIS 125
10.1.6 KEY STRATEGIES 125
10.2 MERZ PHARMA GMBH & CO. KGAA 126
10.2.1 COMPANY OVERVIEW 126
10.2.2 FINANCIAL OVERVIEW 126
10.2.3 PRODUCTS/SERVICES OFFERED 127
10.2.4 KEY DEVELOPMENTS 127
10.2.5 SWOT ANALYSIS 128
10.2.6 KEY STRATEGIES 128
10.3 LUMENIS 129
10.3.1 COMPANY OVERVIEW 129
10.3.2 FINANCIAL OVERVIEW 129
10.3.3 PRODUCTS/SERVICES OFFERED 129
10.3.4 KEY DEVELOPMENTS 130
10.3.5 SWOT ANALYSIS 130
10.3.6 KEY STRATEGIES 130
10.4 HOLOGIC INC. 131
10.4.1 COMPANY OVERVIEW 131
10.4.2 FINANCIAL OVERVIEW 131
10.4.3 PRODUCTS/SERVICES OFFERED 132
10.4.4 KEY DEVELOPMENTS 132
10.4.5 SWOT ANALYSIS 133
10.4.6 KEY STRATEGIES 133
10.5 GALDERMA SA 134
10.5.1 COMPANY OVERVIEW 134
10.5.2 FINANCIAL OVERVIEW 134
10.5.3 PRODUCTS/SERVICES OFFERED 135
10.5.4 KEY DEVELOPMENTS 135
10.5.5 SWOT ANALYSIS 135
10.5.6 KEY STRATEGIES 136
10.6 BAUSCH HEALTH (VALEANT PHARMACEUTICALS) 137
10.6.1 COMPANY OVERVIEW 137
10.6.2 FINANCIAL OVERVIEW 137
10.6.3 PRODUCTS/SERVICES OFFERED 138
10.6.4 KEY DEVELOPMENTS 138
10.6.5 SWOT ANALYSIS 138
10.6.6 KEY STRATEGIES 139
10.7 ANIKA THERAPEUTICS INC. 140
10.7.1 COMPANY OVERVIEW 140
10.7.2 FINANCIAL OVERVIEW 140
10.7.3 PRODUCTS/SERVICES OFFERED 141
10.7.4 KEY DEVELOPMENTS 141
10.7.5 SWOT ANALYSIS 141
10.7.6 KEY STRATEGIES 141
10.8 CUTERA 142
10.8.1 COMPANY OVERVIEW 142
10.8.2 FINANCIAL OVERVIEW 142
10.8.3 PRODUCTS/SERVICES OFFERED 143
10.8.4 KEY DEVELOPMENTS 143
10.8.5 SWOT ANALYSIS 144
10.8.6 KEY STRATEGIES 144
10.9 ALMA LASERS 145
10.9.1 COMPANY OVERVIEW 145
10.9.2 FINANCIAL OVERVIEW 145
10.9.3 PRODUCTS/SERVICES OFFERED 146
10.9.4 KEY DEVELOPMENTS 146
10.9.5 SWOT ANALYSIS 147
10.9.6 KEY STRATEGIES 147
10.10 SYNERON MEDICAL LTD 148
10.10.1 COMPANY OVERVIEW 148
10.10.2 FINANCIAL OVERVIEW 148
10.10.3 PRODUCTS/SERVICES OFFERED 148
10.10.4 KEY DEVELOPMENTS 148
10.10.5 SWOT ANALYSIS 149
10.10.6 KEY STRATEGIES 149
12 APPENDIX
11.1 REFERENCES 150
11.2 RELATED REPORTS 151
